MedPath

DermasilkRx DicloPak

Approved
Approval ID

1c948de4-dbbf-309a-e054-00144ff8d46c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 5, 2015

Manufacturers
FDA

Patchwerx Labs, Inc.

DUNS: 079584480

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

diclofenac sodium delayed release tablets, ranitidine tablets, capsaicin cream

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69329-330
Application NumberANDA074514
Product Classification
M
Marketing Category
C73584
G
Generic Name
diclofenac sodium delayed release tablets, ranitidine tablets, capsaicin cream
Product Specifications
Effective DateAugust 5, 2015
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DermasilkRx DicloPak - FDA Drug Approval Details